Immediate Impact
53 standout
Citing Papers
Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
2024 Standout
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
Works of Daniel A. Ward being referenced
Long-Term and High-Dose Trials of Enzyme Replacement Therapy in the Canine Model of Mucopolysaccharidosis I
1996
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Daniel A. Ward | 359 | 205 | 229 | 53 | 812 | |
| Sheryl G. Krohne | 330 | 204 | 221 | 32 | 719 | |
| Alexandra van der Woerdt | 483 | 208 | 300 | 36 | 858 | |
| L. M. T. Collum | 483 | 409 | 239 | 47 | 982 | |
| Heather L. Chandler | 307 | 243 | 339 | 63 | 923 | |
| Renee L. Kaswan | 388 | 625 | 375 | 33 | 953 | |
| Ronald C. Riis | 159 | 82 | 68 | 43 | 737 | |
| Sheila Crispin | 183 | 112 | 145 | 44 | 749 | |
| R. Messaoud | 619 | 317 | 161 | 56 | 969 | |
| Diane V. H. Hendrix | 534 | 289 | 293 | 62 | 941 | |
| Seema Garg | 203 | 111 | 118 | 58 | 851 |
All Works
Login with ORCID to disown or claim papers
Loading papers...